Christina Lake Cannabis Corp. (CLC.CN)
CAD 0.06
(9.09%)
CAD 0.06
(9.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.62 Million CAD | -123.09% |
| 2022 | -938.92 Thousand CAD | 79.37% |
| 2021 | -5.96 Million CAD | -463.94% |
| 2020 | -2.13 Million CAD | 175.75% |
| 2019 | -24.84 Thousand CAD | -269.92% |
| 2018 | -9510.00 CAD | -294.45% |
| 2017 | -38.27 Thousand CAD | -1570.69% |
| 2016 | -212.00 CAD | -27.2% |
| 2015 | -6973.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -844.42 Thousand CAD | -12.78% |
| 2024 Q3 | 4.82 Million CAD | 666.06% |
| 2024 Q1 | -813.07 Thousand CAD | 81.97% |
| 2023 Q3 | 2.83 Million CAD | 754.02% |
| 2023 FY | - CAD | -123.09% |
| 2023 Q1 | -824.39 Thousand CAD | 77.58% |
| 2023 Q2 | -433.82 Thousand CAD | 47.38% |
| 2023 Q4 | -1.69 Million CAD | -159.67% |
| 2022 Q4 | -3.67 Million CAD | -225.12% |
| 2022 Q3 | 2.93 Million CAD | 24787.28% |
| 2022 FY | - CAD | 79.37% |
| 2022 Q2 | -11.9 Thousand CAD | 97.19% |
| 2022 Q1 | -423.22 Thousand CAD | 94.24% |
| 2021 Q4 | -7.34 Million CAD | -273.65% |
| 2021 FY | - CAD | -463.94% |
| 2021 Q3 | 4.22 Million CAD | 376.03% |
| 2021 Q1 | -1.28 Million CAD | -169.95% |
| 2021 Q2 | -1.53 Million CAD | -18.92% |
| 2020 Q3 | 1.07 Million CAD | 263.2% |
| 2020 FY | - CAD | 175.75% |
| 2020 Q4 | 1.84 Million CAD | 71.56% |
| 2020 Q1 | -604.57 Thousand CAD | 10.03% |
| 2020 Q2 | -657.62 Thousand CAD | -8.77% |
| 2019 FY | - CAD | -269.92% |
| 2019 Q4 | -671.96 Thousand CAD | 43.57% |
| 2019 Q3 | -1.19 Million CAD | -1063.92% |
| 2019 Q2 | -102.3 Thousand CAD | 71.77% |
| 2019 Q1 | -362.37 Thousand CAD | -6613.04% |
| 2018 Q2 | -1314.00 CAD | 49.44% |
| 2018 Q3 | -199.00 CAD | 84.86% |
| 2018 Q4 | -5398.00 CAD | -2612.56% |
| 2018 FY | - CAD | -294.45% |
| 2018 Q1 | -2599.00 CAD | 91.12% |
| 2017 Q4 | -29.28 Thousand CAD | -621.23% |
| 2017 FY | - CAD | -1570.69% |
| 2017 Q1 | -1873.00 CAD | -192.68% |
| 2017 Q3 | -4060.00 CAD | -30.3% |
| 2017 Q2 | -3116.00 CAD | -66.36% |
| 2016 Q4 | 2021.00 CAD | 190.51% |
| 2016 Q1 | - CAD | 100.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | - CAD | -27.2% |
| 2016 Q3 | -2233.00 CAD | 0.0% |
| 2015 Q4 | -185.00 CAD | 86.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | -1321.00 CAD | 75.84% |
| 2015 Q2 | -5467.00 CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 56.806% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -30.488% |
| Blueberries Medical Corp. | -1.22 Million CAD | -114.722% |
| The BC Bud Corporation | -1.19 Million CAD | -119.35% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 59.543% |
| CordovaCann Corp. | -1.6 Million CAD | -63.698% |
| Captor Capital Corp. | 2.42 Million CAD | 208.355% |
| City View Green Holdings Inc. | -2.01 Million CAD | -30.231% |
| 1CM Inc. | 1.31 Million CAD | 299.726% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -10481.418% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -18.795% |
| IM Cannabis Corp. | -2.79 Million CAD | 5.969% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 40.407% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -568.879% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 17.837% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 329.805% |
| Ovation Science Inc. | -778.83 Thousand CAD | -236.844% |
| Pharmadrug Inc. | -1.33 Million CAD | -96.511% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 56.681% |
| RAMM Pharma Corp. | -6.3 Million CAD | 58.372% |
| RIV Capital Inc. | -20.28 Million CAD | 87.064% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 53.111% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 96.619% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 11.091% |
| 1933 Industries Inc. | -10.03 Million CAD | 73.852% |
| Red Light Holland Corp. | -5.25 Million CAD | 50.085% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -241.598% |
| Xebra Brands Ltd. | -1.49 Million CAD | -75.482% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -85.894% |